Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), today announce a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening. Asuragen will leverage its gold-standard PCR technology with Oxford Nanopore's any-read-length DNA sequencing capabilities to develop the first sequencing system to identify the most challenging yet high prevalence carrier genes in a sing
Oxford Nanopore Technologies plc ( LON:ONT ) insiders who purchased shares in the last 12 months were richly rewarded...
Even the best stock pickers will make plenty of bad investments. Anyone who held Oxford Nanopore Technologies plc...